◀ Back to GIP

CCK — GIP

Text-mined interactions from Literome

Ahrén et al., J Clin Endocrinol Metab 2000 (Diabetes Mellitus, Type 2) : In contrast, the increase in the circulating levels of gastric inhibitory polypeptide (GIP) , glucagon-like peptide-1 (GLP-1), or glucagon after meal ingestion was not significantly affected by CCK-8
Takei et al., J Diabetes Complications 2001 (Body Weight...) : There was a small but significant increase in postprandial cholecystokinin (CCK) in responders, and fasting gastric inhibitory peptide (GIP) levels were significantly increased in responders and all patients after treatment
Irwin et al., Int J Obes Relat Metab Disord 2013 (Body Weight...) : Compromise of gastric inhibitory polypeptide (GIP) receptor action and activation of cholecystokinin (CCK) receptors represent mechanistically different approaches to the possible treatment of obesity related diabetes
Sandberg et al., Acta Endocrinol (Copenh) 1988 : Cholecystokinin-33 potentiates and vasoactive intestinal polypeptide inhibits gastric inhibitory polypeptide -- induced insulin secretion in the perfused rat pancreas